The Bioabsorbables/Bioresorbables Center

Filter Your Results

 

News

 

FAST Enrollment Begins for Boston Scientific’s Fully Resorbable Drug-Eluting Scaffold

July 20, 2015 -- Boston Scientific Corporation has initiated the Fully Absorbable Scaffold Feasibility Study (FAST) of the company’s first fully resorbable drug-eluting …

ART’s Bioresorbable Scaffold Receives CE Mark Clearance

May 18, 2015 -- Arterial Remodeling Technologies (ART) has announced European CE Mark clearance for its next-generation, drug-free, pure bioresorbable scaffold for the tr…

Twelve-Month EVOLVE II Data Published for Boston Scientific’s Synergy Bioabsorbable EES

April 8, 2015 -- The 12-month data from the EVOLVE II were published by Dean J. Kereiakes, MD, et al online ahead of print in Circulation: Cardiovascular Interventions. EVOLVE…

EVERBIO II Compares Bioresorbable Vascular Scaffold to New-Generation Drug-Eluting Stents

March 2, 2015 -- Findings from the EVERBIO II study comparing the performance of a bioresorbable vascular scaffold (BVS) with that of everolimus-eluting stents (EES) and bioli…

Enrollment Completed for BIOSOLVE-II Study of Biotronik’s Dreams Bioabsorbable Magnesium Scaffold

February 19, 2015 -- Biotronik has announced the completion of enrollment in the BIOSOLVE-II trial, a clinical study investigating the safety and performance of its product, D…

All-Comers EVERBIO II Study Evaluates Efficacy of Bioresorbable Vascular Scaffold

September 16, 2014 -- The EVERBIO II trial comparing the use of an everolimus-eluting bioresorbable vascular scaffold (BVS) with everolimus-eluting and biolimus-eluting stents…

ABSORB IV Commences Evaluation of Quality of Life and Cost Savings of Abbott’s Bioresorbable Vascular Scaffold

September 15, 2014 -- Abbott Vascular announced the start of the ABSORB IV clinical trial, which will test whether the company’s Absorb bioresorbable vascular …

One-Year ABSORB II Data Support Abbott’s Absorb Bioresorbable Vascular Scaffold

September 14, 2014 -- Abbott Vascular announced 1-year clinical results from the ABSORB II prospective randomized controlled trial comparing the safety and effectiveness of Ab…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.